DrugPatentWatch Database Preview
Details for Patent: 9,050,308
Which drugs does patent 9,050,308 protect, and when does it expire?
This patent has twenty-six patent family members in twenty-two countries.
Summary for Patent: 9,050,308
Title: | DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form |
Abstract: | DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form, therapeutic methods for their use, and processes for refining the compositions from fish oil are presented. |
Inventor(s): | Maines; Timothy J. (Potomac, MD), Machielse; Bernardus N M (North Potomac, MD), Mehta; Bharat M. (Mendham, NJ), Wisler; Gerald L. (Windermere, FL), Davidson; Michael H. (Highland Park, IL), Wood; Peter Ralph (Cotherstone, GB) |
Assignee: | Omthera Pharmaceuticals, Inc. (Princeton, NJ) Chrysalis Pharma AG (Sacheln, CH) |
Application Number: | 13/734,846 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,050,308
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca Pharms | EPANOVA | omega-3-carboxylic acids | CAPSULE;ORAL | 205060-001 | May 5, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | TREATMENT OF HYPERTRIGLYCERIDEMIA | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 9,050,308
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
9,050,309 | DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form | ➤ Sign Up |
Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 9,050,308
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013201793 | ➤ Sign Up | |||
Canada | 2860512 | ➤ Sign Up | |||
Chile | 2014001803 | ➤ Sign Up | |||
China | 104321055 | ➤ Sign Up | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |